Salazar D E, Corcoran G B
School of Pharmacy, State University of New York at Buffalo.
Am J Med. 1988 Jun;84(6):1053-60. doi: 10.1016/0002-9343(88)90310-5.
Existing methods for predicting creatinine clearance provide accurate estimates for normal-weight patients but not for patients who are obese. Studies into this problem began with an animal model of obesity, the obese overfed rat. Mean creatinine clearance was found to vary in direct proportion to fat-free body mass, determined in both obese and normal animals. The relevance of this observation to renal function in humans was evaluated by analyzing published studies reporting creatinine clearance and creatinine excretion rates in obese and normal persons. Measured creatinine clearance correlated well with estimated fat-free body mass (r = 0.772, p less than 0.02), and urinary excretion of creatinine normalized to fat-free mass correlated impressively with age (r = 0.960). Formulas derived from these observations allow for the prediction of creatinine clearance at steady state: (formula; see text) In initial tests of these formulas, their predictions appeared to be as accurate as existing methods for the normal-weight population and far superior to these methods when applied to the obese population. Therefore, when creatinine clearance is not measured in obese patients, the estimation of this parameter with the proposed formulas should improve the ability to select the appropriate dose for drugs that are cleared principally by renal filtration.
现有的预测肌酐清除率的方法可为体重正常的患者提供准确的估计值,但对肥胖患者则不然。针对这一问题的研究始于一种肥胖动物模型——过度喂养的肥胖大鼠。研究发现,无论是肥胖动物还是正常动物,平均肌酐清除率与去脂体重成正比。通过分析已发表的关于肥胖者和正常者肌酐清除率及肌酐排泄率的研究,评估了这一观察结果与人类肾功能的相关性。测得的肌酐清除率与估计的去脂体重相关性良好(r = 0.772,p < 0.02),且以去脂体重标准化后的肌酐尿排泄量与年龄相关性显著(r = 0.960)。根据这些观察结果得出的公式可用于预测稳态时的肌酐清除率:(公式;见原文)在这些公式的初步测试中,其预测结果对于体重正常的人群似乎与现有方法一样准确,而应用于肥胖人群时则远优于这些方法。因此,当未对肥胖患者测量肌酐清除率时,使用所提出的公式估计该参数应能提高为主要通过肾滤过清除的药物选择合适剂量的能力。